Gu et al demonstrated that high expression of LRRK2 promoted the cell proliferation and migration of intrahepatic cholangiocarcinoma (ICC) cells, and predicted worse prognosis in ICC patients [31]. Here, LRRK2 is linked to intrahepatic cholangiocarcinoma.